Plozalizumab

Tax included
Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research.
HY-P99781

Data sheet

Size
Multiple sizes
Reactivity
CCR
Application
Cancer-programmed cell death
CAS
1610761-46-0